Episode 535 - Uromigos Live 2026 – MIBC: The Evolution of Antibody Drug Conjugates (ADCs) in Bladder Cancer
From The Uromigos · · 43 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
ADCs have become a mainstay of systemic therapy in bladder cancer. Where are we headed next? The panel discusses issues around target, payload and sequencing.